BDBM50267989 (2S)-2-(4-chloro-3-((3-(6-methoxybenzo[d]isoxazol-3-yl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl)methyl)phenoxy)propanoic acid::CHEMBL519060

SMILES: COc1ccc2c(noc2c1)-c1c(C)n(Cc2cc(O[C@@H](C)C(O)=O)ccc2Cl)c2cc(OC(F)(F)F)ccc12

InChI Key: InChIKey=SCDKVHCGNOYKFK-HNNXBMFYSA-N

Data: 1 IC50  1 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50267989   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50267989 ((2S)-2-(4-chloro-3-((3-(6-methoxybenzo[d]isoxazol-...) Show SMILES COc1ccc2c(noc2c1)-c1c(C)n(Cc2cc(O[C@@H](C)C(O)=O)ccc2Cl)c2cc(OC(F)(F)F)ccc12 |r,wU:20.22,(26.73,-43.65,;26.71,-42.11,;25.37,-41.35,;25.35,-39.81,;24.02,-39.06,;22.71,-39.84,;21.24,-39.37,;20.34,-40.62,;21.26,-41.86,;22.72,-41.37,;24.05,-42.13,;20.75,-37.92,;21.65,-36.65,;23.19,-36.64,;20.73,-35.4,;21.2,-33.94,;22.71,-33.61,;23.74,-34.74,;25.24,-34.41,;26.28,-35.55,;27.78,-35.22,;28.25,-33.76,;28.82,-36.36,;30.32,-36.03,;28.35,-37.83,;25.71,-32.95,;24.66,-31.8,;23.16,-32.14,;22.12,-31.01,;19.26,-35.89,;17.92,-35.13,;16.6,-35.9,;15.26,-35.13,;15.26,-33.59,;15.25,-32.05,;16.8,-33.58,;13.72,-33.6,;16.59,-37.44,;17.92,-38.22,;19.27,-37.44,)| Show InChI InChI=1S/C28H22ClF3N2O6/c1-14-25(26-21-8-4-17(37-3)12-24(21)40-33-26)20-7-5-19(39-28(30,31)32)11-23(20)34(14)13-16-10-18(6-9-22(16)29)38-15(2)27(35)36/h4-12,15H,13H2,1-3H3,(H,35,36)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents	Article PubMed	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human recombinant PPARgamma expressed in COS1 cells coexpressing GAL4 assessed as transcriptional activity after 48 hrs by lucife...				J Med Chem 52: 3846-54 (2009) Article DOI: 10.1021/jm900097m BindingDB Entry DOI: 10.7270/Q2GF0TDR
					More data for this Ligand-Target Pair
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50267989 ((2S)-2-(4-chloro-3-((3-(6-methoxybenzo[d]isoxazol-...) Show SMILES COc1ccc2c(noc2c1)-c1c(C)n(Cc2cc(O[C@@H](C)C(O)=O)ccc2Cl)c2cc(OC(F)(F)F)ccc12 |r,wU:20.22,(26.73,-43.65,;26.71,-42.11,;25.37,-41.35,;25.35,-39.81,;24.02,-39.06,;22.71,-39.84,;21.24,-39.37,;20.34,-40.62,;21.26,-41.86,;22.72,-41.37,;24.05,-42.13,;20.75,-37.92,;21.65,-36.65,;23.19,-36.64,;20.73,-35.4,;21.2,-33.94,;22.71,-33.61,;23.74,-34.74,;25.24,-34.41,;26.28,-35.55,;27.78,-35.22,;28.25,-33.76,;28.82,-36.36,;30.32,-36.03,;28.35,-37.83,;25.71,-32.95,;24.66,-31.8,;23.16,-32.14,;22.12,-31.01,;19.26,-35.89,;17.92,-35.13,;16.6,-35.9,;15.26,-35.13,;15.26,-33.59,;15.25,-32.05,;16.8,-33.58,;13.72,-33.6,;16.59,-37.44,;17.92,-38.22,;19.27,-37.44,)| Show InChI InChI=1S/C28H22ClF3N2O6/c1-14-25(26-21-8-4-17(37-3)12-24(21)40-33-26)20-7-5-19(39-28(30,31)32)11-23(20)34(14)13-16-10-18(6-9-22(16)29)38-15(2)27(35)36/h4-12,15H,13H2,1-3H3,(H,35,36)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents	Article PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay				J Med Chem 52: 3846-54 (2009) Article DOI: 10.1021/jm900097m BindingDB Entry DOI: 10.7270/Q2GF0TDR
					More data for this Ligand-Target Pair